Search / 4326 results found

from
to

PHILADELPHIA, Jan. 21, 2022 /PRNewswire/ -- After nearly a year in intensive care at Children's Hospital of Philadelphia (CHOP), 10-month-old conjoined twins Addison (Addy) and Lilianna (Lily) Altobelli were successfully separated by CHOP surgeons on October 13, 2021. Now home in Chicago, the girls were born connected at the abdomen and chest, a condition known as thoraco-omphalopagus twins, meaning they shared a liver, diaphragm, chest and abdominal wall.

  • Updated

RADNOR, Pa., Jan. 21, 2022 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed against Chegg, Inc. ("Chegg") (NYSE: CHGG). The action charges Chegg with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company's business, operations, and prospects.  As a result of Chegg's materially misleading statements to the public, Chegg investors have suffered significant losses.

  • Updated

PHILADELPHIA, Jan. 21, 2022 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that the U.S. Food and Drug Administration (FDA) has notified the company that they have completed the safety review of the Investigational New Drug (IND) application for biosimilar insulin glargine, a product the company is co-developing with its strategic alliance partners within the HEC Group of companies (HEC), and concluded that the company may proceed with the proposed clinical investigation. The company said it anticipates the pivotal clinical trial to commence by March 2022 and be completed by early 2023.

  • Updated

PITTSBURGH, Jan. 21, 2022 /PRNewswire/ -- Allegheny Health Network (AHN) physicians have joined a landmark clinical trial exploring the safety and efficacy of deep brain stimulation therapy to treat Alzheimer's disease. Led by  Donald Whiting, MD, chair of AHN's Neurosciences Institute, Chief Medical Officer for AHN, and a pioneer in the use of DBS to treat a variety of debilitating neurological conditions, the ADvance II Study is an international phase 3 clinical trial being offered only at select medical centers world-wide.

  • Updated

RADNOR, Pa., Jan. 20, 2022 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed against Organogenesis Holdings Inc. ("Organogenesis") (NASDAQ: ORGO). The action charges Organogenesis with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company's business, operations, and prospects.  As a result of Organogenesis's materially misleading statements to the public, Organogenesis's investors have suffered significant losses.

  • Updated

BALA CYNWYD, Pa., Jan. 20, 2022 /PRNewswire/ -- Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Denmark Bancshares, Inc. ("Denmark" or the "Company") (OTC - DMKBA) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the Company's agreement to be acquired by Bank First Corporation ("Bank First") (Nasdaq: BFC). Under the terms of the agreement, Denmark's shareholders will have the option to receive either $38.10 in cash or 0.5276 shares of Bank First common stock for each share of Denmark common stock they own.

  • Updated

BALA CYNWYD, Pa., Jan. 20, 2022 /PRNewswire/ -- Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Silver Spike Acquisition Corp. II ("Silver Spike II" or the "Company")(Nasdaq – SPKB) for possible breaches of fiduciary duty and other violations of federal and state law in connection with a merger agreement pursuant to which Silver Spike II, a special purpose acquisition company, will combine with Eleusis, a clinical-stage life science company that aims to unlock the therapeutic potential of psychedelics, and result in Eleusis becoming a publicly-listed company. Under the terms of the agreement, Silver Spike II shareholders will retain ownership of 41% of the combined company.

  • Updated

PHILADELPHIA, Jan. 20, 2022 /PRNewswire/ -- Dianne Semingson, board chair of Avenue of the Arts, Inc., the  organization that champions investment in Philadelphia's theater and cultural arts district on South Broad Street, has announced the addition of five new members to the organization's Board of Directors, effective this month.  The new board members were approved at the group's December board meeting. They include: EEO attorney and consultant Michael A. Bowman, Esquire; sleep specialist Dr. Thanuja Hamilton, developer Brook J. Lenfest, former Cigna CFO Thomas McCarthy and David Yager, president of University of the Arts.

  • Updated

PITTSBURGH, Jan. 20, 2022 /PRNewswire/ -- ANSYS, Inc. (NASDAQ: ANSS) announced today that the Company expects to release its fourth quarter and FY 2021 earnings on Wednesday, February 23, 2022, after the market closes. The Company will hold a conference call conducted by Ajei Gopal, president and chief executive officer and Nicole Anasenes, chief financial officer and senior vice president of finance at 8:30 a.m. Eastern Time on Thursday, February 24, 2022 to discuss fourth quarter and 2021 results and future outlook.

  • Updated

ERIE, Pa., Jan. 20, 2022 /PRNewswire/ --  Erie Indemnity Company (NASDAQ: ERIE) will host a pre-recorded audio webcast with the financial community providing financial results for the fourth quarter and year-end on Friday, February 25th, at 10 a.m. Eastern Time. Erie Indemnity will issue a press release reporting its results after the close of the market on Thursday, February 24th.